• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$92.42 -$0.68 (-0.73%)

REAL-TIME: Last trade at

Alexion Pharmaceuticals, Inc.

NASDAQ:ALXN

Jump to this page for:

Related Resources

7 Biotech Stocks to Add to Your Portfolio

5/26/2012 by InvestorPlace

Alexion Pharmaceuticals 5M share Secondary priced at $93.02

5/25/2012 by Theflyonthewall.com

Today's Economic Outlook - Report Highlights Priceline.com Inc and Alexion Pharmaceuticals, Inc.

5/24/2012 by Marketwire

Alexion Pharmaceuticals (ALXN) To Offer 5M Shares

5/23/2012 by StreetInsider.com

Alexion files automatic equity shelf, no amount given

5/23/2012 by Theflyonthewall.com

Apple, Other Top 5 Big Caps Less Big But Still Strong

5/22/2012 by Investor's Business Daily

Options In Focus: Alexion Pharmaceuticals

5/22/2012 by Investor's Business Daily

Alexion rises on add to S&P 500, resistance is at $92.57

5/22/2012 by Theflyonthewall.com

Alexion Pharmaceuticals added to S&P 500 index

5/21/2012 by Product Design and Development

S&P Indices Announces Change to U.S. Index

5/21/2012 by PR Newswire

Alexion Pharma (ALXN) to Replace Motorola Mobility (MMI) in S&P 500

5/21/2012 by StreetInsider.com

Alexion to be added to S&P 500; Motorola Mobility deleted as of 5/24 close

5/21/2012 by Theflyonthewall.com

Stocks Surge As China Vows Growth Push

5/21/2012 by Investor's Business Daily

Alexion Pharmaceuticals Management Presents at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript)

5/11/2012 by Seeking Alpha

Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference

5/10/2012 by Business Wire

When Momentum Stocks Lose Their Mojo

5/10/2012 by InvestorPlace

Vertex Leads A Big Week For Biotechs

5/9/2012 by Investor's Business Daily

Cramer on the Vertex Conundrum

5/8/2012 by CNBC Video

JP Morgan's biotech analysts hold a conference call on orphan drug coverage

5/8/2012 by Theflyonthewall.com

Vertex Is the Next Gilead Sciences or Alexion

5/7/2012 by TheStreet.com

Alexion drops in early trading, support at $82.63 pivot low

5/7/2012 by Theflyonthewall.com

4 High Growth Stocks Ready For More All Time Highs

5/3/2012 by Seeking Alpha

Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference

4/30/2012 by Business Wire

Oppenheimer updates 2012-2015 EPS Estimates on Alexion Pharmaceuticals (ALXN)

4/25/2012 by StreetInsider.com

Alexion should be bought on weakness, says RW Baird at RW Baird

4/25/2012 by Theflyonthewall.com

Alexion price target raised to $100 from $95 at Canaccord

4/25/2012 by Theflyonthewall.com

Alexion shares should be bought on weakness, says Oppenheimer

4/25/2012 by Theflyonthewall.com

Alexion Beats; Slightly Raises 2012 Outlook

4/24/2012 by Investor's Business Daily

Alexion shares should be bought into Q1 results, says Canaccord

4/24/2012 by Theflyonthewall.com

Alexion concerns overdone, says Goldman

4/24/2012 by Theflyonthewall.com

Alexion Pharmaceuticals - ALXN - Financial results for the three months ended March 31, 2012

4/24/2012 by FutureSource.com

Alexion Pharmaceuticals, Inc. (ALXN) Tops Q1 EPS by 6c; Ups Guidance

4/24/2012 by StreetInsider.com

Alexion Reports First Quarter 2012 Results

4/24/2012 by Business Wire

Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast

4/19/2012 by PR Newswire

Top Analyst Upgrades & Downgrades (ALXN, AAPL, ADP, COCO, EBAY, FFIV, INTC, NAV, ZNGA)

4/19/2012 by 24/7 Wall Street

Alexion Pharmaceuticals (ALXN) - Bull of the Day

4/19/2012 by NASDAQ

Alexion Pharmaceuticals to Report First Quarter 2012 Results on Tuesday, April 24, 2012

4/10/2012 by PharmiWeb.com - UK

Alexion Pharmaceuticals to Report First Quarter 2012 Results on Tuesday, April 24, 2012

4/10/2012 by Business Wire

Baird Reiterates an 'Outperform' on Alexion Pharmaceuticals (ALXN); Enobia Investment Starts Bearing Fruit

3/29/2012 by StreetInsider.com

Asfotase Alfa Significantly Decreased TNSALP Substrates and Improved 6-Minute Walk Test Results in Adolescents and Adults with Hypophosphatasia (HPP)

3/29/2012 by Business Wire
See More Articles...